GV20 Therapeutics
PrivateLast Round
Early Funding
Feb 1, 2025
Total Funding Raised
$30M
Company Overview
GV20 Therapeutics is a biotechnology company that develops antibody therapeutics for cancer treatment by integrating artificial intelligence, genomics, and cancer biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GV20 Therapeutics Comparables
Compare GV20 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 80% | |
| Hummingbird Bioscience | 78% | |
| Generate Biomedicines | 71% | |
GV20 Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 1, 2025 | ||||
| Series B | Oct 14, 2021 | ||||
| Series A | Oct 2, 2018 |
Key People
Founding team and executive leadership
GV20 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series B, Series A |
| Linear Capital | Series B, Series A |
| Coatue Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Selected to deliver late-breaking oral presentation on product GV20-0251.
- Jun 2, 2025
Updated Phase 1 monotherapy data for GV20-0251 presented at ASCO Annual Meeting 2025.
GV20 Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GV20 Therapeutics's valuation, stock price, and market status.